ArticleNature communications2024
Osteopontin is a therapeutic target that drives breast cancer recurrence.
Yu Gu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this paperpooled itcites it
ArticleNature communications2024
Yu Gu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.